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Introduction
Deep vein thrombosis (DVT) and pulmonary embolism (PE) have
been reported as complications after total hip arthroplasty (THA) and
total knee arthroplasty (TKA). However, an effective strategy for
the prevention of such complications has not been established yet.
Because we have experienced a PE case that developed immediately
after THA and there is abundant evidence that many of thrombi occur
intraoperatively (6), we concluded that effective intraoperative control
is necessary to prevent PE immediately after operation. Although
Japanese Guideline for Prevention of Venous Thromboembolism
was published in 2004, it did not show the effective prophylaxis
against PE and/or DVT immediately after THA as our previous case.
To establish an effective prophylaxis against PE and/or DVT im-
mediately after THA, we examined the effects of intraoperative in-
jection of sodium heparinate and investigated its usefulness and
safety.
In the present study, we investigated serial changes in serum
thrombin-antithrombin III complex (TAT) and D-dimer levels as
markers of PE and/or DVT in patients undergoing preventive
antiplatelet and anticoagulant therapies after THA for osteoarthritis
(OA).
Subjects and Methods
Twenty-six women, (mean age, 64.5 years old) who underwent
THA for osteoarthiritis (OA) were included in the present study.
Patients with THA were divided into two groups at random; one
group that had un-fractionated heparin injected during the operation
(1,000 units of sodium heparinate intravenously injected after femo-
ral reaming) (IH Group, 14 patients) and the other group of non-
injection of heparin (NH Group, 12 patients). On the first day after
operation, a total of 5,000 units of un-fractionated sodium heparinate
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【Background】 Recently, the incidences of pulmonary embolism (PE) and/or deep vein thrombosis (DVT) after orthopedic operation increased
in Japan. However the effective prevention methods have not been established yet. To make the effective prevention of PE and/or DVT after
total hip arthroplasty (THA), we investigated the time-dependent changes of serum thrombin-antithrombin III complex (TAT) and D-dimer levels
after THA.
【Subjects & Methods】 We measured changes of serum TAT, and D-dimer levels (before, on day 1, day 5, week 2 and week 4 after opera-
tion). Twenty-six women (mean age 64.5 years old), who had undergone THA for osteoarthritis of the hip joint were enrolled and divided into
two groups at random. One group had been intravenously injected with 1,000 units of heparin during THA (IH Group, 14 patients), and the other
group had not been injected (NH Group, 12 patients).
【Results】 No patients showed clinical PE and/or, DVT. The levels of TAT and D-dimer in IH group significantly reduced compared with these
in NH group on the fifth and first postoperative day, respectively (p < 0.05). There were no severe complications clinically.
【Conclusion】 Our data suggests that intravenous heparin injection during THA might be a potentially effective and safe strategy for prophylaxis
of PE after THA.
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was continuously injected over 24 hours to the all above-mentioned
patients; furthermore, from the second day, one tablet of aspirin (81
mg, Bafferin®) per day for a week and one tablet of ticlopidine hy-
drochloride (100 mg, Panaldine®) per day for three weeks were ad-
ministrated. Levels in TAT and D-dimer in sera were measured be-
fore, day 1, day 5, week 2 and week 4 after operation. All participants
in this study provided informed consent, previously.
Enzyme immunoassay was used to determine TAT, and latex near-
infrared immunoturbidimetric method was used for D-dimer.
Variations in the presence or absence of bone cement, autologous
blood transfusion and epoetin alfa (Espo®), which have been known
to influence TAT and D-dimer, were then studied to confirm whether
the variations observed were specific to heparin injection. Cemented
group contained 10 patients, and non-cemented group contained 16
patients. Autologous blood transfused group contained 14 cases, and
not autologous blood transfused group contained 12 cases. Epoetin
alfa used group contained 12 cases, and epoetin alfa not used group
contained 14 cases (see Table 1).
We defined PE and/or DVT based on only clinical symptoms
(pectoralgia, decrease of arterial partial oxygen pressure, or ECG
abnormalities, which are clinical manifestations indicating the possi-
bility of PE, and pain and enlargement of the lower extremities, or
Homan's sign manifestations indicating DVT).
Values of TAT and D-dimer were statistically compared between
groups by t-test. Differences at P values of less than 0.05 were con-
sidered to be statistically significant.
Results
In the present study, no PE and DVT were observed. The TAT
level was highest on the next day of the operation, and decreased
time-dependently from day 5. On the 5th day after operation, TAT
levels in the IH group were significantly lower than those in the NH
group (Figure 1).
The levels of D-dimer increased on the next day of the operation,
remained high until day 14, then decreased by day 28. D-dimer lev-
els in the IH group were significantly lower than those in the NH
group on the next day of the operation (Figure 2).
Variation in blood volume loss due to heparin injection was com-
pared to examine the safety of intraoperative heparin injection.
Although both intra- and post-opereative blood volume losses in
the IH group were slightly more than those in NH group, there was
no significant difference. Total blood volume loss was significantly
higher in the IH group (Table 2).
TAT and D-dimer were not significantly influenced by the pres-
ence or absence of bone cement, autologous blood transfusion or
epoetin alfa (Figures 3, 4, and, 5)．
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Group No. of Mean age No. of Heparin
patients (years) injection
1. Bone cement
Presence 10 (38.5) 73.4 IH 2, NH 8
Absence 16 (61.5) 59.6 IH 10, NH 6
2. Autologous transfusion
Transfused 14 (53.8) 60.6 IH 8, NH 6
Not transfused 12 (46.2) 69.9 IH 4, NH 8
3. Epoetin alfa
Presence 12 (46.2) 60.5 IH 7, NH 5
Absence 14 (53.8) 68.7 IH 5, NH 9
Table 1. Examination of possible factors affecting Thrombin-Antithrombin
III Complex (TAT) or D-dimer
The numbers show patients in each group. The numbers in parenthesis show the per-
centage of the patients in each group.
IH; group of intraoperative heparin injection. NH; group of non-injection of heparin
Figure 1. Effects of intravenous heparin injection during operation on serum
TAT after THA. TAT in the IH Group is significantly decreased on day 5.
Data show mean±SEM. * : Significantly different (p < 0.05)
Figure 2. Effects of intravenous heparin injection during operation on serum
D-dimer after THA. D-dimer in the IH Group has significantly decreased
on day 1. Data show mean±SEM. * : Significantly different (p < 0.05)








NH 628.9 ± 240.7 289.7 ± 125.6 918.6 ± 289.8
IH 820.8 ± 287.7 363.9 ± 161.9 1184.8 ± 284.3*
Table 2. Effects of intravenous heparin injection during operation on blood volume loss due
to THA
Data show mean±SD. * : Significantly different (p < 0.05)
Figure 4. Effects of autologous blood transfusion on serum TAT and D-dimer after operation. There is no significant difference in either TAT or D-dimer be-
tween the presence or absence of autologous blood transfusion groups. Data show mean±SEM.
Figure 3. Effects of the use of bone cement on serum TAT and D-dimer after operation. There is no significant difference in either TAT or D-dimer between
the presence or absence of bone cement groups. Data show mean±SEM.
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Discussion
Because TAT enables precise tracking of the production of throm-
bin resulting from activation of coagulation, we used high TAT lev-
els as an indicator of promotion of coagulation (1). D-dimer is a
measure of FDP decomposed product D fraction, and an indicator
of promotion of secondary fibrinolysis. Therefore, D-dimer acts as
a sensitive indicator of fibrinolysis of thrombi in the blood vessels
as well as an indicator of the presence of a thrombus (1,2). Thus,
high levels of serum TAT and D-dimer are known to indicate the
presence of PE and DVT. TAT and D-dimer can be measured rela-
tively easily in clinical, therefore we considered these as possible
markers for early detection of DVT and PE.
We have previously reported that a patient who developed DVT
on day 28 after TKA had shown abnormally high levels of TAT on
the day following operation, remaining high until day 28, with D-
dimer increasing steeply on day 14 after operation (3). We have
proposed a relationship between abnormally high levels of TAT
and D-dimer and development of DVT(3). To establish method for
the predictive diagnosis of PE after joint arthroplasty, Kubo et al.
measured TAT, D-dimer, fibrin monomer, and other markers of
thrombophilia time dependently (2). Their data were similar time de-
pendent changes of serum TAT and D-dimer of our NH group.
As preventive strategies to eliminate postoperative thromboembolism,
the various approaches such as mobile soon after operation, elastic
stocking, intermittent pneumatic compression and foot pump, phar-
macological prevention, and filtering of inferior vena cava were re-
ported. Although many prophylaxes have been reported, there is no
one best method of prophylaxis of DVT and/or PE immediately
after THA and/or TKA(4). In the present study, we examined these
approaches with the specific aim of preventing PE and DVT by
means of pharmacological prevention.
We attempted to prevent DVT and PE by means of drugs with dif-
ferent modes of action, specifically heparin, aspirin and ticlopidine.
None of the patients clinically developed DVT and/or PE, and no se-
vere complications due to these preventive treatments were observed.
Our results suggested that the anticoagulant and antiplatelet thera-
pies we conducted prevent DVT and/or PE safely and effectively.
We employed intraoperative heparin injection to prevent PE im-
mediately after THA. The administration dosage of heparin was
determined to 1,000 units (assuming a patient mean weight of 50
kg) according to Sharrock et al. (5), reporting inhibition of fibrin
thrombus formation during THA by 20 units/kg of injected hepa-
rin. Furthermore, Sharrock et al. (5), reported that during THA, there
is minimal activation of thrombogenesis on the acetabulum, but an
immediate activation of thrombosis occurs during surgery on the
femur. Therefore, we decided the timing of the heparin injection
immediately after femoral reaming. In the IH group, D-dimer showed
significantly lower levels on the next day of the operation. We there-
fore conclude that formation of thrombus was inhibited during or
immediate after operation by intraoperative heparin-injection. Nassif
et al (6). reported that many of the factors leading to thromboembolism
occur intraoperatively, and there is abundant evidence that many of the
thrombi occur intraoperatively as well. From these data, intraoperative
heparin injection is very reasonable and effective prevention method
against DVT and/or PE after operation. The reason why intraoperative
heparin-injection affected on the TAT value on 5th day after sur-
gery is unclear, but we thought that this reason might relate to the
high incidence of PE about one week after operation. Additionally,
blood volume loss was higher in the IH group; however, no ho-
mologous blood transfusions were required in patients who had un-
dergone autologous blood transfusions. These results provide evi-
dence that intraoperative heparin injection is a safe and effective
strategy for prevention of DVT and/or PE after THA. Recently, the
12
Figure 5. Effects of epoetin alfa on serum TAT and D-dimer after operation. There is no significant difference in either TAT or D-dimer between the presence
or absence of epoetin alfa groups. Data show mean±SEM.
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low molecule heparin was reported to have less effect on bleeding
tendency than un-fractionated heparin. If we used low molecule
heparin, blood volume losses in IH group might be comparable
with NH group.
In the present study, TAT and D-dimer were not influenced by
utilization of bone cement. In our hospital, bone cement has been
used for the stem fixing of aged patients rigidly and for decreasing
postoperative bleeding from the medullary cavity. The risk of PE
and/or DVT development by bone cementing was considered to be
low. We have been using autologus blood transfusion with epoetin
alfa to prevent infection due to homologous blood transfusion.
Epoetin alfa acts on the hematopoetic stem cells to increase eryth-
rocyte production as well as platelet production (7). For this reason,
we believed that there might be a risk that coagulation ability would
be enhanced by increased numbers of erythrocytes and platelets,
but in the present study, no effects of the use of epoetin alfa on
TAT or D-dimer were found. However, Mukai et al (8). reported
the development of PE after THA in patients autotransfused with
epoetin alfa. Therefore, it must be used with caution and further in-
vestigation will be needed.
In this study, we measured the value of TAT and D-dimer as mark-
ers of PE and/or DVT, but we don't have any case of PE and DVT
clinically. We could not mention about the specific changes of
TAT and D-dimer in PE and DVT cases. However, we could show
the effects of intraoperative heparin injection on the value of TAT
and D-dimer after THA. We need the effective prevention of PE
after THA. Intraoperative heparin injection might be a good pre-
vention method of intra or after operation. Further study is needed
in order to make this prevention method be more effective and safe.
Summary
The time-dependent changes of serum TAT and D-dimer levels in
patients undergoing anticoagulant and antiplatelet therapies after
THA were examined. TAT peaked on the next day of the operation,
and D-dimer peaked from the next day to two weeks postoperatively.
In the intraoperative heparin-injected group, a significant low value
was found in TAT on the 5th day after operation, as well as D-dimer
on the next day of operation compared to those in the non-injected
group. Total blood volume loss was significantly increased in the
heparin-injected group; however, no homologous transfusions were
required in patients transfused with autologous blood. Use of bone
cement, autologous blood transfusion or epoetin alfa showed no in-
fluences on sequential changes in TAT and D-dimer after THA.
Intraoperative heparin injection caused no clinical complications and
were concluded this therapy to be a safe and effective preventative
strategy against PE and/or DVT immediately after THA.
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